Generali Investments Towarzystwo Funduszy Inwestycyjnych
Position in JNJ — Johnson & Johnson
CIK 2043130
WARSAW, R9
Position in JNJ
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$787,307
-$43,789 QoQ
Shares Held
3,100
-8.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.32%
of 13F equity value
Holder Rank
#3,257
of 4,676 holders
Holding Since
Mar 2022
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Generali Investments Towarzystwo Funduszy Inwestycyjnych holds $8,405,860 across 8 Drug Manufacturers - General names. JNJ ranks #5 (9.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PFE |
Pfizer Inc
|
87,000 | $2,094,960 | |
| 2 | LLY |
ELI LILLY & Co
|
1,510 | $1,811,139 | |
| 3 | MRK |
Merck & Co., Inc.
|
14,000 | $1,799,000 | |
| 4 | AMGN |
Amgen Inc
|
2,500 | $905,300 | |
| 5 | JNJ |
Johnson & Johnson
This page
|
3,100 | $787,307 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
10,500 | $605,010 | |
| 7 | ABBV |
AbbVie Inc.
|
1,100 | $276,804 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
1,000 | $126,340 |
All Filings in JNJ
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $787,307 | 3,100 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $831,096 | 3,400 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $703,630 | 3,400 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $778,764 | 4,200 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $740,837 | 4,850 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $804,324 | 4,850 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $1,130,928 | 7,820 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $1,264,878 | 7,805 | Shares | Sole | 2025-02-05 | |
| 2024-06-30 | $1,140,778 | 7,805 | Shares | Sole | 2025-02-05 | |
| 2024-03-31 | $1,084,867 | 6,858 | Shares | Sole | 2025-02-05 | |
| 2023-12-31 | $973,198 | 6,209 | Shares | Sole | 2025-02-05 | |
| 2023-09-30 | $967,051 | 6,209 | Shares | Sole | 2025-02-05 | |
| 2023-06-30 | $1,236,930 | 7,473 | Shares | Sole | 2025-02-05 | |
| 2023-03-31 | $1,128,090 | 7,278 | Shares | Sole | 2025-02-05 | |
| 2022-12-31 | $847,920 | 4,800 | Shares | Sole | 2025-02-05 | |
| 2022-09-30 | $653,440 | 4,000 | Shares | Sole | 2025-02-05 | |
| 2022-06-30 | $727,791 | 4,100 | Shares | Sole | 2025-02-05 | |
| 2022-03-31 | $992,488 | 5,600 | Shares | Sole | 2025-02-05 | |
| No filing history on record for this holder in this stock. | ||||||